Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Financials Score | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.40B | 1.60% | 1.50% | 1.64% | 3.20% | 0.05 | 17.77 | 93.90% | 21.60% | 25.44% | |
| TGTX | TG THERAPEUTICS INC | $2.15B | 12.90% | 4.70% | 9.31% | 12.00% | 1.05 | 5.92 | 94.00% | 5.40% | 10.99% | |
| GMAB | GENMAB A | $18.14B | 14.70% | 13.10% | 21.49% | 38.10% | 0.12 | 13.34 | 98.60% | 26.40% | 42.80% | |
| INCY | INCYTE CORP | $11.49B | 12.40% | 9.50% | 15.10% | 46.10% | 0.31 | 3.75 | 93.10% | 16.20% | 22.64% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.50B | 3.50% | 2.50% | 3.63% | 3.60% | 0.38 | 2.51 | 78.70% | 6.90% | 8.51% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.64B | 27.50% | 16.80% | 30.44% | 50.60% | 0.74 | 2.75 | 79.20% | 22.10% | 33.87% | |
| CORT | CORCEPT THERAPEUTICS INC | $2.30B | 22.00% | 17.90% | 20.63% | 34.40% | 0.23 | 4.39 | 98.70% | 21.90% | 22.11% | |
| MDXG | MIMEDX GROUP INC | $917.76M | 205.30% | 30.10% | 14.44% | 27.90% | 0.68 | 3.57 | 83.00% | 18.10% | 8.67% | |
| HALO | HALOZYME THERAPEUTICS INC | $4.88B | 204.80% | 15.80% | 22.65% | 17.70% | 19.68 | 6.64 | 76.80% | 34.00% | 44.27% | |
| RPRX | ROYALTY PHARMA PLC | $16.79B | 11.50% | 6.80% | 8.15% | 6.20% | 0.62 | 7.90 | 100.00% | 48.20% | 56.15% | |
| VNDA | VANDA PHARMACEUTICALS INC | $257.77M | 0.50% | 0.40% | 1.13% | 2.00% | 0.19 | 4.94 | 92.30% | 1.30% | 3.29% | |
| TECH | BIO-TECHNE CORP | $9.85B | 11.50% | 8.40% | 10.12% | 18.30% | 0.39 | 4.37 | 67.10% | 19.60% | 22.94% | |
| EXEL | EXELIXIS INC | $7.13B | 8.60% | 6.80% | 10.11% | 10.70% | 0.30 | 3.34 | 96.00% | 11.40% | 14.07% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.70B | 11.80% | 3.70% | 5.93% | 8.20% | 2.05 | 2.24 | 88.60% | 10.80% | 15.24% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $235.25M | 58.20% | 10.40% | 27.45% | 31.30% | 3.31 | 1.57 | 73.40% | 9.20% | 15.28% | |
| BNTX | BIONTECH SE | $20.61B | 4.60% | 4.20% | 5.78% | 16.10% | 0.14 | 9.43 | 84.30% | 24.40% | 31.68% | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $120.65M | 12.40% | 10.70% | 12.47% | 22.80% | 0.19 | 5.66 | 93.30% | 12.90% | 14.26% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.73B | 19.80% | 16.50% | 23.98% | 190.70% | 0.21 | 2.88 | 86.90% | 17.90% | 23.73% | |
| NVO | NOVO NORDISK A S | $567.31B | 90.50% | 29.20% | 72.53% | 130.90% | 1.95 | 0.82 | 84.60% | 36.00% | 45.23% | |
| UTHR | UNITED THERAPEUTICS CORP | $11.10B | 17.70% | 14.50% | 20.96% | 22.90% | 0.20 | 4.41 | 88.90% | 42.30% | 57.30% | |
| REGN | REGENERON PHARMACEUTICALS INC | $97.76B | 16.10% | 12.60% | 14.41% | 15.70% | 0.27 | 5.69 | 86.20% | 30.10% | 32.57% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $102.73B | 22.60% | 17.30% | 23.06% | 69.80% | 0.29 | 3.99 | 87.20% | 36.70% | 44.83% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.